Cargando…
Signaling Pathways mTOR and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma
Despite advances in surgery and radiotherapy, the overall prognosis of sinonasal intestinal-type adenocarcinoma (ITAC) is poor, and new treatment options are needed. Recent studies have indicated alterations in cellular signaling pathways that may serve as targets for modern inhibitors. Our aim was...
Autores principales: | Codina-Martínez, Helena, Lorenzo-Guerra, Sara Lucila, Cabal, Virginia N., García-Marín, Rocío, Suárez-Fernández, Laura, Vivanco, Blanca, Sánchez-Fernández, Paula, López, Fernando, Llorente, José Luis, Hermsen, Mario A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606341/ https://www.ncbi.nlm.nih.gov/pubmed/37894790 http://dx.doi.org/10.3390/ijms242015110 |
Ejemplares similares
-
Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors
por: Villanueva-Fernández, Eva, et al.
Publicado: (2022) -
Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma
por: Riobello, Cristina, et al.
Publicado: (2021) -
Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas
por: López, Luis, et al.
Publicado: (2023) -
Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma
por: Sánchez-Fernández, Paula, et al.
Publicado: (2021) -
CD8(+) Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
por: García-Marín, Rocío, et al.
Publicado: (2020)